Scroll to explore events active on this date.
There are several unique focuses for 2025. I covered the first 12 in Part One. The following are the rest I have discovered for this year. As with all issues of LEEP Ink, the following descriptions are a...
We've arrived at another new year; the older I get, the more frequently they come. When I was younger, years seemed to take a long time to pass. Now, they're just a blip—here and gone. For ma...
21 Themes and 'Year of' Events for 2025 PART ONE, THE FIRST 12 Every year, various organizations announce the theme for the year. These themes can focus on causes, such as aesthetics and color tre...
The American Hemochromatosis Society (AHS) champions National Hereditary Hemochromatosis Genetic Screening and Awareness Month in May; it previously ran in July. Canada conducts a similar campaign within their borders.
National Hereditary Hemochromatosis Genetic Screening and Awareness Month was founded in 1998 by Josephine Bogie Thomas, who succumbed to complications from the disease in 1999. AHS seeks to raise awareness and encourage people to get tested for Hereditary Hemochromatosis (HH), commonly called iron overload disease, iron storage disease, or genetic iron poisoning.
The Centers for Disease Control and Prevention lists Hereditary Hemochromatosis as America's most common genetic disease. One in eight people, or 33 million Americans, are carriers of the disease, and most don't know it. Mutations of the disease can manifest as full-blown Hereditary hemochromatosis. It can affect anyone, men, women, and children at any stage of life affect men, women, and children at any age.
Hereditary hemochromatosis is an inherited disorder that causes the body to absorb too much iron from the diet. The excess iron is then stored in various organs, such as the liver, heart, and pancreas, potentially leading to life-threatening conditions like liver disease, heart problems, and diabetes.
Mutations in the HFE gene cause the most common form of hereditary hemochromatosis. Early symptoms of the disorder may include joint pain, fatigue, and weakness. If left untreated, it can result in more severe health issues, including liver cirrhosis, heart failure, and diabetes. Early detection and treatment can help prevent or reduce complications.
Genetic screening for hereditary hemochromatosis is crucial, particularly for individuals of Northern European descent, who are more likely to carry HFE gene mutations. Screening involves a blood test for elevated iron levels and specific gene mutations. If the condition is diagnosed early, treatment can be as simple as regular blood donations or therapeutic phlebotomy to remove excess iron from the body.